These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 24206230

  • 1. Advanced technologies for studying circulating tumor cells at the protein level.
    Chan CM, Au TC, Chan AT, Ma BB, Tsui NB, Ng SS, Hui EP, Chan LW, Ho WS, Yung BY, Wong SC.
    Expert Rev Proteomics; 2013 Dec; 10(6):579-89. PubMed ID: 24206230
    [Abstract] [Full Text] [Related]

  • 2. Circulating tumor cells: detection, molecular profiling and future prospects.
    Jacob K, Sollier C, Jabado N.
    Expert Rev Proteomics; 2007 Dec; 4(6):741-56. PubMed ID: 18067413
    [Abstract] [Full Text] [Related]

  • 3. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES, Strati A, Markou A.
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [Abstract] [Full Text] [Related]

  • 4. Microfluidics and circulating tumor cells.
    Dong Y, Skelley AM, Merdek KD, Sprott KM, Jiang C, Pierceall WE, Lin J, Stocum M, Carney WP, Smirnov DA.
    J Mol Diagn; 2013 Mar; 15(2):149-57. PubMed ID: 23266318
    [Abstract] [Full Text] [Related]

  • 5. Overview of current standpoints in profiling of circulating tumor cells.
    Kim K, Lee KH, Lee J, Choi J.
    Arch Pharm Res; 2014 Jan; 37(1):88-95. PubMed ID: 24214218
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
    O'Flaherty JD, Gray S, Richard D, Fennell D, O'Leary JJ, Blackhall FH, O'Byrne KJ.
    Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
    [Abstract] [Full Text] [Related]

  • 8. Technologies for label-free separation of circulating tumor cells: from historical foundations to recent developments.
    Jin C, McFaul SM, Duffy SP, Deng X, Tavassoli P, Black PC, Ma H.
    Lab Chip; 2014 Jan 07; 14(1):32-44. PubMed ID: 23963515
    [Abstract] [Full Text] [Related]

  • 9. Clinical significance of cytokeratin 20-positive circulating tumor cells detected by a refined immunomagnetic enrichment assay in colorectal cancer patients.
    Wong SC, Chan CM, Ma BB, Hui EP, Ng SS, Lai PB, Cheung MT, Lo ES, Chan AK, Lam MY, Au TC, Chan AT.
    Clin Cancer Res; 2009 Feb 01; 15(3):1005-12. PubMed ID: 19188172
    [Abstract] [Full Text] [Related]

  • 10. Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.
    Paterlini-Bréchot P.
    Future Oncol; 2011 Jul 01; 7(7):849-71. PubMed ID: 21732757
    [Abstract] [Full Text] [Related]

  • 11. Circulating levels of transforming growth factor-βeta (TGF-β) and chemokine (C-X-C motif) ligand-1 (CXCL1) as predictors of distant seeding of circulating tumor cells in patients with metastatic breast cancer.
    Divella R, Daniele A, Savino E, Palma F, Bellizzi A, Giotta F, Simone G, Lioce M, Quaranta M, Paradiso A, Mazzocca A.
    Anticancer Res; 2013 Apr 01; 33(4):1491-7. PubMed ID: 23564790
    [Abstract] [Full Text] [Related]

  • 12. Image cytometry analysis of circulating tumor cells.
    Lowes LE, Goodale D, Keeney M, Allan AL.
    Methods Cell Biol; 2011 Apr 01; 102():261-90. PubMed ID: 21704842
    [Abstract] [Full Text] [Related]

  • 13. Development of a molecular multimarker assay for the analysis of circulating tumor cells in adenocarcinoma patients.
    de Albuquerque A, Kubisch I, Ernst D, Breier G, Stamminger G, Fersis N, Stölzel U, Boese-Landgraf J, Eichler A, Kaul S.
    Clin Lab; 2012 Apr 01; 58(5-6):373-84. PubMed ID: 22783565
    [Abstract] [Full Text] [Related]

  • 14. Circulating tumour cells in clinical practice: Methods of detection and possible characterization.
    Alunni-Fabbroni M, Sandri MT.
    Methods; 2010 Apr 01; 50(4):289-97. PubMed ID: 20116432
    [Abstract] [Full Text] [Related]

  • 15. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
    Danova M, Torchio M, Mazzini G.
    Expert Rev Mol Diagn; 2011 Jun 01; 11(5):473-85. PubMed ID: 21707456
    [Abstract] [Full Text] [Related]

  • 16. Essentials of circulating tumor cells for clinical research and practice.
    Liberko M, Kolostova K, Bobek V.
    Crit Rev Oncol Hematol; 2013 Nov 01; 88(2):338-56. PubMed ID: 23830807
    [Abstract] [Full Text] [Related]

  • 17. Immunomagnetic separation technologies.
    Hoeppener AE, Swennenhuis JF, Terstappen LW.
    Recent Results Cancer Res; 2012 Nov 01; 195():43-58. PubMed ID: 22527493
    [Abstract] [Full Text] [Related]

  • 18. Automated genotyping of circulating tumor cells.
    Stakenborg T, Liu C, Henry O, Borgen E, Laddach N, Roeser T, Ritzi-Lehnert M, Fermér C, Hauch S, O'Sullivan CK, Lagae L.
    Expert Rev Mol Diagn; 2010 Sep 01; 10(6):723-9. PubMed ID: 20843197
    [Abstract] [Full Text] [Related]

  • 19. Circulating tumor cells: utopia or reality?
    Conteduca V, Zamarchi R, Rossi E, Condelli V, Troiani L, Aieta M.
    Future Oncol; 2013 Sep 01; 9(9):1337-52. PubMed ID: 23980681
    [Abstract] [Full Text] [Related]

  • 20. Strategies for Isolation and Molecular Profiling of Circulating Tumor Cells.
    Chen JY, Chang YC.
    Adv Exp Med Biol; 2017 Sep 01; 994():43-66. PubMed ID: 28560667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.